david cloutier director, research center management and development
DESCRIPTION
Budgeting for Industry Sponsored Clinical Trials. David Cloutier Director, Research Center Management and Development. Objectives. Describe costs associated with clinical trial conduct Review a sample internal budget Identify hidden costs Identify the elements of sponsor budget - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: David Cloutier Director, Research Center Management and Development](https://reader036.vdocuments.site/reader036/viewer/2022070403/56813a06550346895da1d1a6/html5/thumbnails/1.jpg)
David CloutierDirector, Research Center Management and
Development
Budgeting for Industry Sponsored Clinical Trials
![Page 2: David Cloutier Director, Research Center Management and Development](https://reader036.vdocuments.site/reader036/viewer/2022070403/56813a06550346895da1d1a6/html5/thumbnails/2.jpg)
Objectives
• Describe costs associated with clinical trial conduct
• Review a sample internal budget• Identify hidden costs • Identify the elements of sponsor budget• Describe post award activities related to
payment and budget changes
![Page 3: David Cloutier Director, Research Center Management and Development](https://reader036.vdocuments.site/reader036/viewer/2022070403/56813a06550346895da1d1a6/html5/thumbnails/3.jpg)
Budget Prioritization
Prioritize budget analysis and feasibility• Request a draft budget and protocol as soon
as you are approached for the trial• The budget and contract can take as long to
negotiate as the Informed Consent Document• You can make a draft budget while waiting on
the sponsor’s budget
![Page 4: David Cloutier Director, Research Center Management and Development](https://reader036.vdocuments.site/reader036/viewer/2022070403/56813a06550346895da1d1a6/html5/thumbnails/4.jpg)
Interest and feasibility
Study the protocol carefullyIs the project feasible for your site
• Academic / Scientific interest• Resources• Research staff• Patient population
Identify Your CostsReview the Protocol Schematic and Informed Consent Document
![Page 5: David Cloutier Director, Research Center Management and Development](https://reader036.vdocuments.site/reader036/viewer/2022070403/56813a06550346895da1d1a6/html5/thumbnails/5.jpg)
Review the Protocol Schematic
• Hospital procedures (technical fees)• Physician practice costs (professional fees)• Lab costs• How many visits / Length of study• Visits until randomization• Coordinator time per visit / post visit
Compare to visits and procedures listed in the informed consent document
![Page 6: David Cloutier Director, Research Center Management and Development](https://reader036.vdocuments.site/reader036/viewer/2022070403/56813a06550346895da1d1a6/html5/thumbnails/6.jpg)
![Page 7: David Cloutier Director, Research Center Management and Development](https://reader036.vdocuments.site/reader036/viewer/2022070403/56813a06550346895da1d1a6/html5/thumbnails/7.jpg)
Build the Budget
• Per Patient Costs• Study Level Costs
![Page 8: David Cloutier Director, Research Center Management and Development](https://reader036.vdocuments.site/reader036/viewer/2022070403/56813a06550346895da1d1a6/html5/thumbnails/8.jpg)
Per Patient Costs
• Breakdown procedures by Coordinator, Physician, and Hospital Fees– ECG cost / Pro Fees / Coordinator filing– Lab tests / review / CRF filing– ECHO cost / Pro Fees / CRF filing– Medical History / CRF filing– Dispensing fees
• Assign costs for coordinator / staff time• Apply Indirect Cost rate
– 25% Industry Sponsored Trials
![Page 9: David Cloutier Director, Research Center Management and Development](https://reader036.vdocuments.site/reader036/viewer/2022070403/56813a06550346895da1d1a6/html5/thumbnails/9.jpg)
Coordinator Fees
• Regulatory document collection / filing
• Correspondence filing
• Case Report Form completion, submission
• Scheduling for pt visits, tests/scans
• Participant stipend processing
• Data query resolution
• Sponsor invoicing / accounts receivable
![Page 10: David Cloutier Director, Research Center Management and Development](https://reader036.vdocuments.site/reader036/viewer/2022070403/56813a06550346895da1d1a6/html5/thumbnails/10.jpg)
Study Level Costs
• Administrative Startup Fee• Pharmacy Set Up Fee• Document archiving, offsite storage• Advertising• Unscheduled visits• SAE reporting• Monitor visits• IRB Fees
– Initial Review, Amendments, Renewals
![Page 11: David Cloutier Director, Research Center Management and Development](https://reader036.vdocuments.site/reader036/viewer/2022070403/56813a06550346895da1d1a6/html5/thumbnails/11.jpg)
• Protocol Review• Site Initiation Visit• Contract and Budget Review• Investigator Meeting • Regulatory Documentation filing• Initial IRB Application preparation / submission• Informed Consent Document
– IRB Requested Revisions– Negotiating ICD w/ Sponsor
• Office Supplies
Startup Fee ($1500 - $5000)
![Page 12: David Cloutier Director, Research Center Management and Development](https://reader036.vdocuments.site/reader036/viewer/2022070403/56813a06550346895da1d1a6/html5/thumbnails/12.jpg)
Hidden Costs
• Extended start-up activities / timeline
• Pre-screening activities
• Increased hospital procedure costs
• Unscheduled visits
• Tracking study accounts receivable
• Query resolution
• Amendments
![Page 13: David Cloutier Director, Research Center Management and Development](https://reader036.vdocuments.site/reader036/viewer/2022070403/56813a06550346895da1d1a6/html5/thumbnails/13.jpg)
The Sponsor Budget
• Per Patient Amount comparable?
• Study Level costs covered?
• Indirect cost rate correct?
• Enrollment goals feasible?
• Screen failure reimbursement acceptable?
![Page 14: David Cloutier Director, Research Center Management and Development](https://reader036.vdocuments.site/reader036/viewer/2022070403/56813a06550346895da1d1a6/html5/thumbnails/14.jpg)
Negotiating
• Internal budget will differ from sponsor offer• Discourage sharing detailed internal budget with sponsor• Your internal costs may limit negotiation of future
projects• Sponsors retain database of previously negotiated
budgetsNegotiate reimbursement at the same level of detail as sponsor template– Per-visit reimbursements are acceptable– Line item expenses are acceptable
![Page 15: David Cloutier Director, Research Center Management and Development](https://reader036.vdocuments.site/reader036/viewer/2022070403/56813a06550346895da1d1a6/html5/thumbnails/15.jpg)
Sponsor Payment Terms
• What is the payment schedule?– Ad Hoc– Quarterly– After Monitor Visits and CRF auditing
• Are they relying on you to Invoice?– For all payments– Study Level Costs– Per Visit
![Page 16: David Cloutier Director, Research Center Management and Development](https://reader036.vdocuments.site/reader036/viewer/2022070403/56813a06550346895da1d1a6/html5/thumbnails/16.jpg)
Track your payments
• Budget statement• Payment memo• Invoice for your “Study Level Costs” and
reimbursable expenses• Sponsors miss payments• Request periodic payment reports from sponsors to
ensure that EFTs were received and directed to the correct fund-org
• Some sponsors rely on you to invoice for all the visits.
![Page 17: David Cloutier Director, Research Center Management and Development](https://reader036.vdocuments.site/reader036/viewer/2022070403/56813a06550346895da1d1a6/html5/thumbnails/17.jpg)
Initial Payment
Initial payment may include pre-payment Untangle start-up fees from initial payment by negotiating a
“non-refundable” start-up fee
![Page 18: David Cloutier Director, Research Center Management and Development](https://reader036.vdocuments.site/reader036/viewer/2022070403/56813a06550346895da1d1a6/html5/thumbnails/18.jpg)
Re-Negotiation is an Option
• Review protocol amendments for new work…– If the amendment changes work load or adds
procedures: re-negotiate– If sponsor allows more patients to be enrolled,
request more screen failures